Cole, Carmelita P.

HRN: 09-82-70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2026
CEFTAZIDIME 1GM (VIAL)
08/02/2026
08/08/2026
IV
2gm
Q8
CAP MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: